These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4122564)

  • 21. Assessment of the biologic availability of digoxin in man.
    Fleckenstein L; Kroening B; Weintraub M
    Clin Pharmacol Ther; 1974 Sep; 16(3):435-43. PubMed ID: 4606249
    [No Abstract]   [Full Text] [Related]  

  • 22. The absorption of digoxin tablets.
    Binnion PF
    Clin Pharmacol Ther; 1974 Nov; 16(5 Part 1):807-12. PubMed ID: 4426149
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-equivalence of digoxin tablets.
    Reissell P; Manninen V; Ojala K; Karjalainen J
    Ann Clin Res; 1974; 6(0):suppl 11:4-8. PubMed ID: 4853359
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic non-equivalence of digoxin tablets in the United Kingdom: correlation with tablet dissolution rate.
    Shaw TR; Raymond K; Howard MR; Hamer J
    Br Med J; 1973 Dec; 4(5895):763-6. PubMed ID: 4758573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of digitoxin bioavailability from tablets and elixir during maintenance therapy (author's transl)].
    Ochs H; Bodem G; Hahn E; Dengler HJ
    Klin Wochenschr; 1975 May; 53(9):425-9. PubMed ID: 1152354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioavailability of digoxin tablets and elixir in the fasting and postprandial states.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    Clin Pharmacol Ther; 1974 Sep; 16(3):444-8. PubMed ID: 4412196
    [No Abstract]   [Full Text] [Related]  

  • 28. Digoxin preparations: variation in biological availability.
    McCredie RM; Cody DV; Mackie AM; Ng KK; Worner FL; Chow M; Milstead G
    Med J Aust; 1973 Nov; 2(20):922-5. PubMed ID: 4765886
    [No Abstract]   [Full Text] [Related]  

  • 29. Bioavailability of digoxin: what the clinician needs to know.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    Conn Med; 1974 May; 38(5):230-2. PubMed ID: 4831099
    [No Abstract]   [Full Text] [Related]  

  • 30. Intersubject variation in absorption of digoxin in normal volunteers.
    Huffman DH; Manion CV; Azarnoff DL
    J Pharm Sci; 1975 Mar; 64(3):433-7. PubMed ID: 1151628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of particle size on the bioavailability of digoxin.
    Jounela AJ; Pentikäinen PJ; Sothmann A
    Eur J Clin Pharmacol; 1975 Jun; 8(5):365-70. PubMed ID: 1233237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability of digoxin in a new soluble pharmaceutical formulation in capsules.
    Ghirardi P; Catenazzo G; Mantero O; Merotti GC; Marzo A
    J Pharm Sci; 1977 Feb; 66(2):267-9. PubMed ID: 839426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Appraisal of digoxin bioavailability and pharmacokinetics in relation to cardiac therapy.
    Wagner JG
    Am Heart J; 1974 Aug; 88(2):133-8. PubMed ID: 4601506
    [No Abstract]   [Full Text] [Related]  

  • 34. A completely absorbed oral preparation of digoxin.
    Johnson BF; Bye C; Jones G; Sabey GA
    Clin Pharmacol Ther; 1976 Jun; 19(6):746-51. PubMed ID: 1269214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absorption of digoxin from different oral preparations in normal subjects during steady state.
    Huffman DH; Manion CV; Azarnoff DL
    Clin Pharmacol Ther; 1974 Aug; 16(2):310-7. PubMed ID: 4850376
    [No Abstract]   [Full Text] [Related]  

  • 36. Dissolution-rates and bioavailability of digoxin tablets.
    Fraser EJ; Leach RH; Poston JW; Bold AM; Culank LS; Lipede AB
    Lancet; 1973 Jun; 1(7816):1393. PubMed ID: 4122785
    [No Abstract]   [Full Text] [Related]  

  • 37. Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation.
    Bochner F; Huffman DH; Shen DD; Azarnoff DL
    J Pharm Sci; 1977 May; 66(5):644-7. PubMed ID: 874745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability and dissolution properties of two commercial digoxin tablets.
    Klink PR; Poust RI; Colaizzi JL; McDonald RH
    J Pharm Sci; 1974 Aug; 63(8):1231-4. PubMed ID: 4850764
    [No Abstract]   [Full Text] [Related]  

  • 39. Particle size and absorption of digoxin.
    Shaw TR; Carless JE; Howard MR; Raymond K
    Lancet; 1973 Jul; 2(7822):209-10. PubMed ID: 4124293
    [No Abstract]   [Full Text] [Related]  

  • 40. Dissimilarities of digoxin.
    Goldfinger SE
    N Engl J Med; 1971 Dec; 285(24):1376-7. PubMed ID: 5121194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.